◆ 会议时间：2024年5月15-17日
◆ 会议地点：德国 柏林（Berlin, Germany）

◆ 会议简介：

2024年欧洲肿瘤内科学会(ESMO)乳腺癌年会/大会将于2024年5月15-17日在德国柏林举行。ESMO乳腺癌年会是在欧洲举行的一个多学科全球会议，由全球公认的一流专家参与，是所有对创新、转化肿瘤学和护理感兴趣的乳腺癌研究人员和临床医生的进行交流的平台，预计有超过800名专业人士出席会议。

欧洲肿瘤内科学会（ESMO）成立于1975年，是欧洲领先的肿瘤内科学专业组织，现在全球150多个国家和地区拥有超过23,000名会员，是肿瘤学教育和信息的参考学会，ESMO致力于支持其会员在快速发展的专业环境中得到宣发展与进步。作为一个非营利组织，ESMO一直以推动癌症护理和治疗为使命，致力于推进肿瘤医学专业的发展，以多学科的方法来促进癌症的治疗和护理。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.

ESMO BREAST CANCER ANNUAL CONGRESS 2024
Date: 15-17 May 2024
Venue: Messe Berlin, Berlin, Germany

Organized by: European Society for Medical Oncology (ESMO)

Cancer patients and their needs are at the heart of what we do – we are committed to advancing research and integrating it into the clinic to ensure better care for our patients. 

We aim to deliver a comprehensive overview of all the practice-changing new data and to make sure it has a clear roadmap to the clinic.

Mark your calendar and join a global community of experts and advocates presenting and discussing the latest ground-breaking developments and forging powerful new partnerships.

We look forward to welcoming you to ESMO Breast Cancer 2024. 

摘要征文投稿：

Abstract submission deadlines

点此提交摘要>>>Submit Abstract>>>

• 提交指南>>>ESMO Breast Cancer 2024 Abstract Regulations

Outcome notifications

Outcome notifications of regular abstracts are expected to be made available to first authors and submitters by end-March 2024.

Outcome notifications of accepted full LBAs are expected to be made available to first authors and submitters by end-April 2024.

Information for presenters 

Detailed instructions for the preparation of slide presentations and/or posters will be made available by end-March in the section “Information for Presenters”. 

Abstract submission categories

• Biomarkers and translational research and precision medicine
• Early breast cancer: Systemic treatments
• Early breast cancer: Surgery and radiotherapy
• Early detection, hereditary breast cancer and prevention
• Metastatic breast cancer
• Supportive care and survivorship
• Miscellaneous

Late-breaking abstracts

Late-breaking abstracts may be submitted for high quality, new research findings with implications for clinical practice or understanding of disease processes.

The final late-breaking abstract deadline of 17 April 2024 is under no circumstances to be considered as an extension of the general submission deadline (13 February 2024).

Trial in Progress abstracts

Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to ESMO Breast Cancer 2024.

It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis.

Presentation and publication of accepted abstracts

The Breast Cancer 2024 Scientific Committee will select abstracts for presentation during the Congress and determine the format of the presentations from the following possibilities:

• Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives. 
• Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
• Poster – Display session for review, discussion and questions. The presenting authors must be available for Q&A to represent their work.

All accepted abstracts, including Late-breaking, will be published online in the ESMO Breast Cancer 2024 Abstract Book, a supplement to the official ESMO journal, ESMO Open.

Publication schedule of accepted abstracts

Abstracts accepted for presentation during the ESMO Breast Cancer 2024 will be released online according to a schedule which will be available on the ESMO website in due course.

ESMO Merit Travel Grant

A restricted number of ESMO Merit Travel Grants to the ESMO Breast Cancer 2024 are available, upon application, to first author (= presenter) who submit abstracts considered to be deserving of recognition. Candidates must be ESMO Members under the age of 40. Selection will be made by the ESMO Breast Cancer 2024 Scientific Committee on a competitive basis from among the accepted abstracts.

ESMO BC 注册费：

In-person participation includes:

• Participation in scientific and educational live sessions with the possibility to interact with the expert panel
• Onsite networking opportunity with faculty and peers
• Entry to the Poster and e-Poster area
• Interaction with the industry partners in the trade exhibition
• Participation in the Industry Satellite Symposia
• Access to the Virtual Platform to view the missed sessions on-demand
• Post-event resources
• Coffee breaks and lunches

Online participation includes:

• Access to the virtual platform, with live streaming of all sessions
• Possibility to interact through the chat live discussion
• Access to e-Posters
• Entry to the virtual exhibition
• Participation in the Industry Satellite Symposia
• Post-event resources

Please note that until 24 April 2024 an onsite registration can be changed to online and vice versa, at no additional charge.

Registration fees and deadlines

Individual registration will remain open for the duration of the congress. The ESMO Congress Secretariat must receive one completed registration per participant and the corresponding payment in EUR by the given deadlines.

ESMO membership must be active seven (7) days prior to the registration deadline for the reduced member registration fee to be applied. Please visit the membership page to check eligibility criteria, benefits, and to complete the membership application.

*Applicable to ESMO Members from developing countries only. At the time of application, developing countries are defined by ESMO according to the World Bank classification of low, lower-middle and upper-middle countries based on the Gross National Income (GNI) per capita. Download the PDF outlining which countries are eligible for the discounted registration fees.
** ESMO Members must be under 40 and in training to qualify for this fee

Confirmation

By end April 2024 delegates will receive the registration confirmation email and instructions on how to access the ESMO Breast Cancer 2024.

◆ 参会对象：
肿瘤科医师、乳腺外科医师，妇科医师，乳腺科医师，胸外科医师，普外科医师，介入放射科医师，病理科医师，护士以及从事肿瘤护理与研究的其他相关专业人士等。